Literature DB >> 16533060

Restoring full biological activity to the isolated ectodomain of an integral membrane protein.

Emily K Waters1, James H Morrissey.   

Abstract

Integral membrane proteins, which include many cellular effector proteins and drug targets, can be difficult to produce, purify, and manipulate. Although the isolated ectodomains of many membrane proteins can be expressed as water soluble proteins, biological activity is frequently lost when these proteins are released from the membrane surface. An example is tissue factor, the integral membrane protein that triggers the blood clotting cascade and for which membrane anchoring is essential. Its isolated ectodomain (soluble tissue factor) can be expressed with high yield in bacteria but is orders of magnitude less active than the intact, membrane-anchored protein. We now report full restoration of biological activity to the isolated tissue factor ectodomain via the engineering of a hexahistidine tag onto its C-terminus and its use in combination with membrane bilayers containing nickel-chelating lipids. When soluble tissue factor was tethered to the membrane surface via such metal-chelating lipids, it bound factor VIIa with the same high affinity as wild-type tissue factor, and the resulting factor VIIa-tissue factor complexes supported factor X activation and factor VII autoactivation with essentially wild-type enzyme kinetic constants. Furthermore, when such bilayers were immobilized onto solid supports, they efficiently captured histidine-tagged soluble tissue factor directly from crude culture supernatants, with full biological activity, obviating the need for purification or laborious membrane reconstitution procedures. This strategy is rapid, efficient, scalable, and automatable and should be applicable to other integral membrane proteins, especially those with a single transmembrane domain. Applications include high-throughput screening of mutants or drugs, flow reactors, clinical assays, and point-of-care instrumentation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533060      PMCID: PMC2525505          DOI: 10.1021/bi052600m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.

Authors:  T Nakagaki; D C Foster; K L Berkner; W Kisiel
Journal:  Biochemistry       Date:  1991-11-12       Impact factor: 3.162

2.  Attaching histidine-tagged peptides and proteins to lipid-based carriers through use of metal-ion-chelating lipids.

Authors:  Ghania G Chikh; Wai Ming Li; Marie-Paule Schutze-Redelmeier; Jean-Claude Meunier; Marcel B Bally
Journal:  Biochim Biophys Acta       Date:  2002-12-23

3.  Monoclonal antibody analysis of purified and cell-associated tissue factor.

Authors:  J H Morrissey; D S Fair; T S Edgington
Journal:  Thromb Res       Date:  1988-11-01       Impact factor: 3.944

4.  Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor.

Authors:  C H Gemmell; G J Broze; V T Turitto; Y Nemerson
Journal:  Blood       Date:  1990-12-01       Impact factor: 22.113

5.  Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.

Authors:  D Repke; C H Gemmell; A Guha; V T Turitto; G J Broze; Y Nemerson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 6.  Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapy.

Authors:  Robert A Lazarus; Alan G Olivero; Charles Eigenbrot; Daniel Kirchhofer
Journal:  Curr Med Chem       Date:  2004-09       Impact factor: 4.530

7.  Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine.

Authors:  P F Neuenschwander; E Bianco-Fisher; A R Rezaie; J H Morrissey
Journal:  Biochemistry       Date:  1995-10-31       Impact factor: 3.162

8.  Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function.

Authors:  W Ruf; A Rehemtulla; J H Morrissey; T S Edgington
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

9.  Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade.

Authors:  J H Morrissey; H Fakhrai; T S Edgington
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

10.  Rapid and efficient incorporation of tissue factor into liposomes.

Authors:  S A Smith; J H Morrissey
Journal:  J Thromb Haemost       Date:  2004-07       Impact factor: 5.824

View more
  9 in total

1.  Tissue Factor Residues That Modulate Magnesium-Dependent Rate Enhancements of the Tissue Factor/Factor VIIa Complex.

Authors:  Joshua M Gajsiewicz; Kristin M Nuzzio; Chad M Rienstra; James H Morrissey
Journal:  Biochemistry       Date:  2015-07-27       Impact factor: 3.162

2.  Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.

Authors:  N J Mutch; E K Waters; J H Morrissey
Journal:  J Thromb Haemost       Date:  2012-10       Impact factor: 5.824

3.  Factor VII and protein C are phosphatidic acid-binding proteins.

Authors:  Narjes Tavoosi; Stephanie A Smith; Rebecca L Davis-Harrison; James H Morrissey
Journal:  Biochemistry       Date:  2013-08-07       Impact factor: 3.162

Review 4.  Structure-Function Relationship of the Interaction between Tissue Factor and Factor VIIa.

Authors:  Joshua M Gajsiewicz; James H Morrissey
Journal:  Semin Thromb Hemost       Date:  2015-09-26       Impact factor: 4.180

5.  Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes.

Authors:  Bryan H Lin; Michael R Sutherland; Federico I Rosell; James H Morrissey; Edward L G Pryzdial
Journal:  J Thromb Haemost       Date:  2020-04-09       Impact factor: 5.824

6.  A coagulation defect arising from heterozygous premature termination of tissue factor.

Authors:  Sol Schulman; Emale El-Darzi; Mary Hc Florido; Max Friesen; Glenn Merrill-Skoloff; Marisa A Brake; Calvin R Schuster; Lin Lin; Randal J Westrick; Chad A Cowan; Robert Flaumenhaft; Willem H Ouwehand; Kathelijne Peerlinck; Kathleen Freson; Ernest Turro; Bruce Furie
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

7.  Molecular determinants of phospholipid synergy in blood clotting.

Authors:  Narjes Tavoosi; Rebecca L Davis-Harrison; Taras V Pogorelov; Y Zenmei Ohkubo; Mark J Arcario; Mary C Clay; Chad M Rienstra; Emad Tajkhorshid; James H Morrissey
Journal:  J Biol Chem       Date:  2011-05-11       Impact factor: 5.157

8.  A serine loop in tissue factor mediates substrate selectivity by the tissue factor-factor VIIa complex.

Authors:  Fabienne Birkle; James H Morrissey
Journal:  J Thromb Haemost       Date:  2020-10-01       Impact factor: 5.824

9.  Tissue factor residues that putatively interact with membrane phospholipids.

Authors:  Ke Ke; Jian Yuan; James H Morrissey
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.